- New state-of-the-art vaccine plant to hire 200 staff in Singapore - GSK and the Singapore Economic Development Board (EDB) set up endowment fund" Singapore's pharmaceutical industry has moved into higher gear, with the opening of a state-of-the-art vaccine plant. The new plant is GlaxoSmithKline's (GSK) first primary vaccine manufacturing facility and its biggest investment in Asia. The plant, which involves a total investment of S$600 million, underscores GSK's strong commitment to Singapore." - siwaporn from Bookmarklet